• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EMD 3.13% 3.1¢

EMYRIA LIMITED

Emyria Limited is an Australia-based clinical services and drug development company. The... Emyria Limited is an Australia-based clinical services and drug development company. The Company is focused on developing patient outcomes in neuroscience and mental health through its clinical service delivery, proprietary real-world data (RWD), and drug discovery & development. It delivers evidence-based and emerging therapies for mental health and other unmet needs through its Emerald Clinics and the Pax Centre. Emerald Clinics specializes in providing treatments for patients with complex and chronic conditions. The Pax Centre specializes in treating individuals grappling with the psychological impacts of traumatic experiences. Through its advanced data platform operated by Palantir, the Company collects robust and ethically sourced real-world data to improve its care models and support its distinct therapy and drug development initiatives. The Company is also developing several proprietary ultra-pure cannabinoid dose forms and advancing them towards registration, such as EMD-RX5.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) reports record revenue growth, European market expansion and strategic cost savings

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
EMD
general talk
5 6 7
18/10/24 368 133K
18/10/24 Last post  rasberry Comments Created with Sketch.  368  Views Created with Sketch.  133K 
EMD 13/10/24 3 991
13/10/24 Last post  6beersaday Comments Created with Sketch.  3  Views Created with Sketch.  991 
EMD 11/10/24 0 170
TRENDING NEWS

NAB: Even the banks look at HotCopper

NEWS
22 Oct 2024
11/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  170 
EMD 11/10/24 0 199
11/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  199 
EMD 11/10/24 0 145
11/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  145 
EMD 27/09/24 14 4.7K
27/09/24 Last post  rasberry Comments Created with Sketch.  14  Views Created with Sketch.  4.7K 
EMD
Is Monash working with EMD?
17:12 2 881
17:12 Last post  MirCat Comments Created with Sketch.  2  Views Created with Sketch.  881 
EMD 12:58 0 266
12:58 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  266 

See All Discussions arrow Created with Sketch.

Timeline

Letter to Shareholders - Notice of Annual General Meeting
11 Oct 15:53
 
Notice of Annual General Meeting/Proxy Form
11 Oct 15:52
 
Appendix 4G and Corporate Governance Statement
11 Oct 15:50
 
Annual Report
11 Oct 15:50
 
Change of Director's Interest Notice x 2
23 Sep 12:38
 
Section 708A(5)(e) Notice
20 Sep 17:26
 
View More arrow Created with Sketch.
(20min delay)
Last
3.1¢
Change
-0.001(3.13%)
Mkt cap ! $12.87M
Open High Low Value Volume
3.0¢ 3.2¢ 3.0¢ $1.795K 57.44K

Buyers (Bids)

No. Vol. Price($)
3 67999 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 43183 2
View Market Depth
Last trade - 14.34pm 22/10/2024 (20 minute delay) ?
Last
3.1¢
  Change
-0.001 ( 3.33 %)
Open High Low Volume
3.2¢ 3.2¢ 3.1¢ 41399
Last updated 14.34pm 22/10/2024 ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.